Biotech · Private company
Accutar Biotechnology Inc
Track this companyFree. Adds Accutar Biotechnology Inc to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- AC176Phase 1 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- AC676Phase 1 · Relapsed/Refractory B-cell MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- AC682Phase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- AC699Phase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell MalignanciesPHASE1 · RECRUITING · started Jun 20, 2023ClinicalTrials.gov NCT05780034 · fetched Nov 12, 2026
- Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 29, 2022ClinicalTrials.gov NCT05654532 · fetched Nov 12, 2026
- A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate CancerPHASE1 · TERMINATED · started Mar 16, 2022ClinicalTrials.gov NCT05241613 · fetched Nov 12, 2026
- A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast CancerPHASE1 · TERMINATED · started Nov 12, 2021ClinicalTrials.gov NCT05080842 · fetched Nov 12, 2026